Return to Article Details
EFFICACY AND SAFETY OF PCSK9 INHIBITORS IN REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Download
Download PDF